Expansion of the Medicare 340B Payment Program Hospital Participation, Prescribing Patterns and Reimbursement, and Legal Challenges

被引：5
作者：
Bach, Peter B. [1 ]
Sachs, Rachel E. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes Res Grp, 1275 York Ave, New York, NY 10021 USA
[2] Washington Univ, Sch Law, St Louis, MO USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 320卷 / 22期
关键词：
CONSEQUENCES;
D O I：
10.1001/jama.2018.15667
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2311 / 2312
页数：2
相关论文
共 9 条
[1]  
[Anonymous], COST REP FISC YEAR
[2]  
Bach PB, DOES 6 MEDICARE B
[3]   The 340B Drug Discount Program: Hospitals Generate Profits By Expanding To Reach More Affluent Communities [J].
Conti, Rena M. ;
Bach, Peter B. .
HEALTH AFFAIRS, 2014, 33 (10) :1786-1792
[4]   Cost Consequences of the 340B Drug Discount Program [J].
Conti, Rena M. ;
Bach, Peter B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (19) :1995-1996
[5]   Consequences of the 340B Drug Pricing Program [J].
Desai, Sunita ;
McWilliams, J. Michael .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (06) :539-548
[6]  
Drug Channels Institute, 340B PROGR REACH 19
[7]  
Medicare Payment Advisory Commission, OV 340B DRUG PRIC PR
[8]  
US Government Accountability Office, DRUG DISC PROGR CHAR
[9]  
US Government Accountability Office, DRUG DISC PROGR FED
1